Robert Lenk

Robert Lenk

Presidente en
Lenk Pharmaceuticals, LLC
.

Fortuna: 21 568 $ al 31/07/2026

78 años
Health Technology
Finance
Electronic Technology

Perfil

Robert P.
Lenk
was the founder of The Liposome Co., Inc., founded in 1981, and Argus Pharmaceuticals, Inc., founded in 1989, where the title held was Vice President-Research & Development.
Current jobs include Director at POP Biotechnologies, Inc., Partner at Houston Partners Private Equity Group LLC, and President at Lenk Pharmaceuticals, LLC since 2016.
Former jobs include President & Chief Executive Officer at Therapeutics 2000, Inc. from 1995 to 2003, Independent Non-Executive Director at Plus Therapeutics, Inc. from 2020 to 2026, President-Luna Nanoworks Division at Luna Innovations, Inc. from 2004 to 2010, President at OncoVector, Inc., and Chief Scientific Officer at MediVector, Inc. from 2010 to 2016.
Education includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/03/2026 5.573 ( 0,08 % ) 21 568 $ 31/07/2026

Cargos activos de Robert Lenk

EmpresasCargoInicio
Corporate Officer/Principal -
Lenk Pharmaceuticals, LLC
Presidente 01/01/2016
Director/Miembro de la Junta -

Antiguos cargos conocidos de Robert Lenk.

EmpresasCargoFin
CERENOME, INC. Director/Miembro de la Junta 20/03/2026
Director Técnico/Científico/I+D 01/01/2016
LUNA INNOVATIONS INCORPORATED Corporate Officer/Principal 15/04/2010
Therapeutics 2000, Inc.
Director Ejecutivo 01/09/2003
Fundador -
Ver el detalle de la experiencia de Robert Lenk.

Formación de Robert Lenk.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

35

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Electronic Technology

Health Technology

Finance

Finance

Health Technology

Commercial Services

OncoVector, Inc.

Therapeutics 2000, Inc.

Lenk Pharmaceuticals, LLC

Health Technology